The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma

被引:23
作者
Roh, Michael H. [1 ]
Schmidt, Lindsay [1 ]
Placido, Jeremiah [1 ]
Farmen, Sara [1 ]
Fields, Kristina L. [1 ]
Courey, Anthony J. [2 ]
Arenberg, Douglas A. [2 ]
Knoepp, Stewart M. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
关键词
napsin-A; TTF-1; p63; cytology; lung cancer; METASTATIC LUNG ADENOCARCINOMA; TRANSCRIPTION FACTOR-I; NAPSIN-A; CANCER; P63; IDENTIFICATION; EXPRESSION; SPECIMENS; THERAPY; TISSUE;
D O I
10.1002/dc.21680
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The importance of subclassifying pulmonary nonsmall cell carcinoma (NSCLC) in cytologic material is becoming increasingly paramount. Occasionally, cell blocks traditionally used for ancillary studies are sparsely cellular or acellular. Hence, we investigated the diagnostic utility of immunocytochemistry for Napsin-A, TTF-1, and p63 on direct smears of NSCLC. Immunohistochemistry for Napsin-A was initially tested on a tissue microarray (TMA) composed of pulmonary adenocarcinoma. Subsequently, in 25 cases, immunocytochemistry for Napsin-A, TTF-1, and p63 was performed on cytologic direct smears. Smears were prepared from tumor cells scraped from lung resection specimens (n = 10), endobronchial ultrasound-guided transbronchial fine-needle aspirates (n = 13), and pelleted cell material from pleural effusions (n = 2). Immunohistochemistry utilizing the TMA revealed Napsin-A positivity in 73% of pulmonary ADCs. Next, immunocytochemistry on direct cytologic smears demonstrated a Napsin-A(+)/TTF-1(+) immunophenotype in 15 of 18 adenocarcinomas; p63 was completely negative (n = 12) or only focally positive (n = 3) in these 15 adenocarcinomas. The remaining three adenocarcinomas were negative for all three markers. All six squamous cell carcinomas were Napsin-A(-)/TTF-1(-) and diffusely p63(+). In conclusion, direct smears represent a feasible and robust source of cellular material for immunocytochemical studies to diagnose pulmonary ADC and SQC. Our method allows the cytologist to confirm on site that material for diagnostic immunocytochemistry is present thereby serving as a safeguard in instances where the cell block is of insufficient cellularity. Diagn. Cytopathol. 2012. (c) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:949 / 955
页数:7
相关论文
共 24 条
[1]  
ABENDROTH CS, 1995, ACTA CYTOL, V39, P379
[2]  
[Anonymous], 2004, PATHOLOGY GENETICS T
[3]   p63 expression in lung carcinoma - A tissue microarray study of 408 cases [J].
Au, NHC ;
Gown, AM ;
Cheang, M ;
Huntsman, D ;
Yorida, E ;
Elliott, WM ;
Flint, J ;
English, J ;
Gilks, CB ;
Grimes, HL .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) :240-247
[4]   Targeted therapies in lung cancer [J].
Besse, B. ;
Ropert, S. ;
Soria, J. C. .
ANNALS OF ONCOLOGY, 2007, 18 :135-142
[5]   Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma [J].
Bishop, Justin A. ;
Sharma, Rajni ;
Illei, Peter B. .
HUMAN PATHOLOGY, 2010, 41 (01) :20-25
[6]   Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas [J].
Chuman, Y ;
Bergman, AC ;
Ueno, T ;
Saito, S ;
Sakaguchi, K ;
Alaiya, AA ;
Franzén, B ;
Bergman, T ;
Arnott, D ;
Auer, G ;
Appella, E ;
Jörnvall, H ;
Linder, S .
FEBS LETTERS, 1999, 462 (1-2) :129-134
[7]   Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions [J].
Dejmek, Annika ;
Naucler, Pontus ;
Smedjeback, Anita ;
Kato, Harubumi ;
Maeda, Masahiro ;
Yashima, Koichi ;
Maeda, Junichi ;
Hirano, Takashi .
DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (08) :493-497
[8]   Toxicities of antiangiogenic therapy in non-small-cell lung cancer [J].
Herbst, Roy S. .
CLINICAL LUNG CANCER, 2006, 8 :S23-S30
[9]   Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma [J].
Hirano, T ;
Gong, YB ;
Yoshida, K ;
Kato, Y ;
Yashima, K ;
Maeda, M ;
Nakagawa, A ;
Fujioka, K ;
Ohira, T ;
Ikeda, N ;
Ebihara, Y ;
Auer, G ;
Kato, H .
LUNG CANCER, 2003, 41 (02) :155-162
[10]  
Jagirdar J, 2008, ARCH PATHOL LAB MED, V132, P384, DOI 10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO